Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction

JACC: Cardiovascular Interventions

Volumn 5, Issue 3, 2012, Pages 259-267

  Ahn, Sung Gyun ^a   Lee, Seung Hwan ^a   Yoon, Jin Ha ^a   Kim, Woo Taek ^a   Lee, Jun Won ^a   Youn, Young Jin ^a   Ahn, Min Soo ^a   Kim, Jang Young ^a   Yoo, Byung Su ^a   Yoon, Junghan ^a   Choe, Kyung Hoon ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

coronary angioplasty; drug effects; myocardial infarction; platelet activation; platelet function test

Indexed keywords

PURINERGIC P2Y12 RECEPTOR;

ACUTE HEART INFARCTION; ADULT; AGED; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; HIGH ON TREATMENT PLATELET REACTIVITY; HUMAN; KOREA; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; REVIEW; STENT THROMBOSIS; THROMBOCYTE FUNCTION;

EID: 84863338161     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.12.009     Document Type: Article

References (30)

1. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
2. M.J. Price, S. Endemann, R.R. Gollapudi Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
3. T. Cuisset, C. Frere, J. Quilici High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome J Thromb Haemost 4 2006 542 549
4. S. Matetzky, B. Shenkman, V. Guetta Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
5. N.J. Breet, J.W. van Werkum, H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
6. R. Marcucci, A.M. Gori, R. Paniccia Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up Circulation 119 2009 237 242
7. M.J. Price, P.B. Berger, P.S. Teirstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
8. L. Bonello, U.S. Tantry, R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
9. M.J. Price Bedside evaluation of thienopyridine antiplatelet therapy Circulation 119 2009 2625 2632
10. K.W. Park, J.J. Park, K.H. Jeon Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans Cardiovasc Ther 30 2012 5 11
11. J.W. Suh, S.P. Lee, K.W. Park Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial J Am Coll Cardiol 57 2011 280 289
12. Y.G. Ko, J.W. Suh, B.H. Kim Comparison of 2 point-of-care platelet function tests, VerifyNow assay and multiple electrode platelet aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention Am Heart J 161 2011 383 390
13. K. Lee, S.W. Lee, J.W. Lee The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the Verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation Korean Circ J 39 2009 512 518
14. C.P. Cannon, A. Battler, R.G. Brindis American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130 (Pubitemid 33116592)
15. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
16. L. Bonello, L. Camoin-Jau, S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411 (Pubitemid 351447314)
17. L. Bonello, L. Camoin-Jau, S. Armero Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol 103 2009 5 10
18. M. Valgimigli, G. Campo, N. de Cesare Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study Circulation 119 2009 3215 3222
19. K.W. Lee, G.Y. Lip, M. Tayebjee, W. Foster, A.D. Blann Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes Blood 105 2005 526 532 (Pubitemid 40070731)
20. P.A. Gurbel, K.P. Bliden, I.A. Navickas Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events Am Heart J 160 2010 346 354
21. M.D. Trip, V.M. Cats, F.J. van Capelle, J. Vreeken Platelet hyperreactivity and prognosis in survivors of myocardial infarction N Engl J Med 322 1990 1549 1554 (Pubitemid 20176694)
22. P.C. Elwood, S. Renaud, A.D. Beswick, J.R. O'Brien, P.M. Sweetnam Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort Heart 80 1998 578 582 (Pubitemid 28561692)
23. M.J. Price, K.R. Nayak, C.M. Barker, D.E. Kandzari, P.S. Teirstein Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
24. I.S. Kim, B.R. Choi, Y.H. Jeong, C.H. Kwak, S. Kim The CYP2C19 (*)2 and CYP2C19 (*)3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome J Thromb Haemost 7 2009 897 899
25. J.L. Mega, S.L. Close, S.D. Wiviott Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes Circulation 119 2009 2553 2560
26. T. Simon, C. Verstuyft, M. Mary-Krause Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
27. J.A. Goldstein, T. Ishizaki, K. Chiba Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations Pharmacogenetics 7 1997 59 64 (Pubitemid 27153320)
28. G. Campo, G. Parrinello, P. Ferraresi Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483
29. S.G. Ahn, S.H. Lee, J.K. Sung, J.Y. Kim, J. Yoon Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention Platelets 22 2011 305 307
30. S. Arméro, L. Camoin Jau, O. Omar At Mokhtar Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy Platelets 21 2010 503 507